journal logo

Welcome to Cancer Gene Therapy

The essential gene and cellular therapy resource for cancer researchers and clinicians.


  • Cancer Gene Therapy welcome your submissions for consideration for a special issue on 'Self-replicating RNA/virus strategies in Cancers'. Click to find out more information about the special issue, how to submit and when. We look forward to seeing your work.

  • Cancer Gene Therapy is participating in a pilot of NISO/STM's Working Group on Peer Review Terminology. to identify and standardize definitions and terminology in peer review practices. Please see the section entitled Peer Review Terminology under the Guide for Authors, Editorial Process or For Referees for more information and to locate the link to complete the short survey.

  • Each month or so we will be featuring one of our editorial team, allowing them an opportunity to impart some of their wisdom and knowledge with you, our authors and readers, and you the opportunity to get to know them a little better. Currently featuring Associate Editor, Leandro Castellano

  • New QC checks introduced in CGT

    As part of CGT’s continuous effort to provide high quality & innovative research, we have introduced new QC checks: Requirement of a cover letter in an institutional letterhead at first submission; Requirement for institutional e-mail(s) addresses for the corresponding author(s); Inclusion of an Author Contribution statement in the submitted manuscript; Availability of original data upon request

Cancer Gene Therapy is a Transformative Journal; authors can publish using the traditional publishing route OR via immediate gold Open Access.

Our Open Access option complies with funder and institutional requirements.


Gastric Cancer

Gastric cancer is among the leading cause of cancer-related mortality worldwide. Despite the fact that early diagnosis has improved quality of life and patient outcomes, better understanding of the biology of the disease is needed to design better therapies. Currently, advances in treatment of gastric cancer have been limited mainly due to this neoplasia’s genetic heterogeneity. Consequently, several efforts have been made to further improve our knowledge of gastric cancer biology. In this CGT collection, we include articles focusing on cell signalling, epigenetic mechanisms and immune responses implicated in gastric cancer thus shedding light on novel potential therapeutic strategies.